Pneumonologia i alergologia polska
-
Pneumonol Alergol Pol · Jan 2008
Case Reports[Wegener's granulomatosis presenting with ischaemic stroke].
Wegener's granulomatosis (WG) is a systemic disease of unknown origin characterized by necrotizing granulomatous vasculitis that involves primarily the upper and the lower respiratory tracts and the kidneys. A 44-year-old woman presenting with unusual neurological manifestation is reported. ⋯ A diagnosis of WG was confirmed by histological examination of specimen obtained during open lung biopsy. During the combination chemotherapy with prednisolone and cyclophosphamide, neurological symptoms decreased and clinical condition significantly improved.
-
This article presents a review of ultrasonographic methods and their usefulness in pulmonary diagnostics. Because of its advantages ultrasonography offers a quick, cheap, and safe diagnostics of variety of pulmonary diseases. ⋯ Some restrictions of this tool were mentioned. The newest methods of endobronchial ultrasound were also discussed.
-
Pneumonol Alergol Pol · Jan 2008
The prevalence of tobacco smoking and attitudes of Polish pulmonologists towards smoking.
Pulmonologists can play an important role in smoking prevention and control. The aim of this study was to assess smoking prevalence among Polish pulmonologists and physicians' behaviour towards smoking patients. ⋯ This study found a lower prevalence of smoking among Polish pulmonologists compared with the general population, and with the previous surveys and demonstrated the impact of personal smoking on physicians' attitudes towards smoking.
-
Pneumonol Alergol Pol · Jan 2008
Case Reports[Long-term remission after erlotinib therapy in an elderly patient with advanced non-small-cell lung cancer. Case report and conclusions for clinical practice].
Small molecule tyrosine kinase inhibitors (TKIs) of epidermal growth factor receptor (EGFR) - gefitinib and erlotinib - have recently been used as a therapeutic option in advanced non-small cell lung cancer (NSCLC) patients relapsing after first- or second-line chemotherapy. We report here a case of long-term remission in an elderly, non-smoking woman with advanced NSCLC after chemotherapy failure, who was selected for erlotinib therapy using demographic and clinical criteria. Based on this example and on the literature data we discuss the need for careful patient selection for this new therapeutic method.